Combinatorial Chemistry in Drug Design « New Drug Approvals:
'via Blog this'
Tracks information on drugs on worldwide basis by Dr Anthony Melvin Crasto, helping millions with websites, 9 million hits on google, 2.5 lakh connections worldwide, P.S. : The views expressed are my personal and in no-way suggest the views of the professional body or the company that I represent.
Friday, 8 November 2013
Wednesday, 6 November 2013
Pfizer Receives FDA Approval for a Prior Approval Supplement for EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII « New Drug Approvals
Tuesday, 5 November 2013
Dexniguldipine hydrochloride, (R)-Niguldipine hydrochloride
Dexniguldipine hydrochloride, (R)-Niguldipine hydrochloride
BY-935, B8509-035, B-844-39(racemate), B-859-34 [(-)-(S)-isomer], B-859-35
(R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-methyl 5-[3-(4,4-diphenyl-1-piperidinyl)propyl] diester hydrochloride
113145-70-3, 113165-32-5 ((-)-enantiomer, free base), 120054-86-6 (free base), 102993-22-6 (undefined isomer, free base)
CAS No. | 189624-85-9 |
Chemical Name: | (R)-(-)-NIGULDIPINE HYDROCHLORIDE |
Synonyms: | By 935;B859-35;(S)-Ae0047;Dexniguldipine hydrochloride;(R)-Nigaldipine hydrochloride; (-)-Nigaldipine hydrochloride;(R)-(-)-NIGULDIPINE HYDROCHLORIDE; (S)-(+)-Watanidipine hydrochloride,; (R)-1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID, 3-(4,4-DIPHENYL-1-PIPERIDINYL)PROPYL METHYL ESTER HYDROCHLORIDE; R(-)-1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)- 3,5-PYRIDINE-DICARBOXYLIC ACID 3-(4,4-DIPHENYL-1-PIPERIDINYL)- PROPYL METHYL ESTER HYDROCHLORIDE |
Molecular Formula: | C36H39N3O6 |
Formula Weight: | 609.71 |
Modulators of the Therapeutic Activity of Antineoplastic Agents, Multidrug Resistance Modulators, ONCOLYTIC DRUGS
Phase II
The reaction of diketene (I) with 2-bromoethanol (II) by means of dimethylaminopyridine (DMAP) in dichloromethane gives acetoacetic acid 2-bromoethyl ester (III), which is condensed with 3-nitrobenzaldehyde (IV) by means of piperidine acetate in isopropanol yielding the corresponding 3-nitrobenzylidene derivative (V). The cyclization of (V) with methyl 3-aminocrotonate (VI) by heating at 80 affords 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(2-bromoethyl) 5-methyl diester (VII), which is condensed with chloromethyl ethyl ether (VIII) by means of NaH in THF to afford the corresponding 1-ethoxymethyl derivative (IX). The reaction of diester (IX) with NaCN and tetrabutylammonium cyanide or sodium p-toluenesulfonate and benzyltriethylammonium chloride (BTEACl) in DMF gives 1-(ethoxymethyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5 -dicarboxylic acid monomethyl ester (X). The optical resolution of (X) through the cinchonidine salt yields, after crystallization, the cinchonidine salt of the (R)-enantiomer (XI) (1), which is treated with HCl to eliminate the cinchonidine, and esterified with 1,3-dibromopropane and K2CO3 in acetone to afford (R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(3-bromopropyl) 5-methyl diester (XII). Finally, this compound is condensed with 4,4-diphenylpiperidine (XIII) by means of K2CO3 in DMF at 100
References
1. Amschler, H., Flockerzi, D., Klemm, K. et al. (Byk Gulden Lomberg Chem. Fabrik GmbH). 1,4-Dihydropyridine enantiomers. AU 8816264, EP 296316, EP 343193, WO 8807525.
2. Klemm, K., Ulrich, W.-R., Flockerzi, D., Sanders, K., Beller, K.-D. (Gyk Gulden Lomberg Chem. Fabrik GmbH). Optically pure (R)-(-)-niguldipine and its derivs. for treating tumor diseases. WO 8907443.
1. Amschler, H., Flockerzi, D., Klemm, K. et al. (Byk Gulden Lomberg Chem. Fabrik GmbH). 1,4-Dihydropyridine enantiomers. AU 8816264, EP 296316, EP 343193, WO 8807525.
2. Klemm, K., Ulrich, W.-R., Flockerzi, D., Sanders, K., Beller, K.-D. (Gyk Gulden Lomberg Chem. Fabrik GmbH). Optically pure (R)-(-)-niguldipine and its derivs. for treating tumor diseases. WO 8907443.
Monday, 4 November 2013
New Drug Approvals « All you want to know about Drugs, live, by DR ANTHONY MELVIN CRASTO, Worlddrugtracker, Helping millions, million hits on google, pushing boundaries, one lakh connections worldwide, my soul in action for you round the clock, dedicated to my family, only live blog in the world, 100000 plus VIEWS achieved in 166 countries……………………………………… Please do not wait, just scroll down the page to view contents
New Drug Approvals « All you want to know about Drugs, live, by DR ANTHONY MELVIN CRASTO, Worlddrugtracker, Helping millions, million hits on google, pushing boundaries, one lakh connections worldwide, my soul in action for you round the clock, dedicated to my family, only live blog in the world, 100000 plus VIEWS achieved in 166 countries……………………………………… Please do not wait, just scroll down the page to view contents:
'via Blog this'
'via Blog this'
Subscribe to:
Posts (Atom)